Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.M. Franklin
Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results From the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) Study
Metabolism: Clinical and Experimental
Endocrinology
Metabolism
Diabetes
Preoperative Opioid Use and Short-Term Safety Events Following Total Knee Replacement Surgery
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Related publications
Pdb15 - Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb12 - Cardiovascular Safety of Empagliflozin Versus Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb76 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Liraglutide Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ce1 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Empagliflozin/Linagliptin Single-Tablet Combination: First-In-Class Treatment Option
International Journal of Clinical Practice
Medicine
TAS-102 Safety in Metastatic Colorectal Cancer: Results From the First Postmarketing Surveillance Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Empagliflozin in Type 1 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects
Drug Metabolism and Pharmacokinetics
Pharmacology
Pharmaceutical Science
Diabetische Ketoazidose Unter Empagliflozin
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
